Business Wire

n-Lorem Foundation Organizes Third Annual Nano-rare Patient Colloquium, Highlighting Scientific and Clinical Advancements Achieved Since Organization’s Founding

SAN DIEGO--(BUSINESS WIRE)--n-Lorem, a nonprofit foundation, announced today that it will hold its third annual Nano-rare Patient Colloquium in Cambridge, Mass., where n-Lorem leaders and experts in ...
Morningstar

n-Lorem Foundation Celebrates Five Years of Bringing Hope and Potential Treatments to Nano-rare Patients

n-Lorem has received more than 330 applications and accepted more than 160 patients for potential treatment with personalized experimental ASOs discovered and developed completely in-house. n-Lorem ...
MarketWatch

n-Lorem Foundation Identifies New, Important Roles of JIP3, Offering Critical Insights into Therapeutic Approaches for Nano-rare Patients

-- Research, supported by the Wolverine Foundation and published in JCI Insights, characterizes a mutation in MAPK8IP3 that disrupts dopamine signaling SAN DIEGO--(BUSINESS WIRE)--May 08, 2025-- ...
Business Wire

GondolaBio and n-Lorem Foundation Partner to Advance Novel ASO Therapies for Genetic Diseases

PALO ALTO, Calif. & SAN DIEGO--(BUSINESS WIRE)--n-Lorem, a nonprofit foundation, and GondolaBio, a clinical-stage biotechnology company founded in 2024 and dedicated to developing novel medicines for ...
Morningstar

n-Lorem Foundation Organizes Third Annual Nano-rare Patient Colloquium, Highlighting Scientific and Clinical Advancements Achieved Since Organization’s Founding

n-Lorem, a nonprofit foundation, announced today that it will hold its third annual Nano-rare Patient Colloquium in Cambridge, Mass., where n-Lorem leaders and experts in the field will share updates ...